Scientific and practical peer-reviewed journal for cardiologists and general practice physicians. Issued since 2005
ISSN 1819-6446 (Print) ISSN 2225-3653 (Online)
I.A. Latfullin, A.A. Podolskaya*
Chair of Internal Medicine N 2, Kazan State Medical University, ul. Butlerova 49, 420012 Kazan, Republic Tatarstan, Russia
Clinical efficacy of unfractionated and low molecular heparins in acute coronary syndrome is discussed. New synthetic heparin derivative fondaparinux (Arixtra) is focused. Author’s brief experience of fondaparinux clinical implementation is presented.
Key words: acute coronary syndrome, anticoagulants, fondaparinux.
Rational Pharmacother. Card. 2009;3:71-75
*Corresponding author: raushania13 (at) rambler.ru